Abstract:Background and purpose: We performed a meta-analysis to assess whether leukoaraiosis on brain computed tomographic scans of acute ischemic stroke patients treated with intravenous thrombolysis is associated with an increased risk of symptomatic intracerebral hemorrhage (sICH) or poor functional outcome at 3 to 6 months after stroke, or both. Methods: We searched PubMed and pooled relevant data in meta-analyses using random effects models. Using odds ratios (OR), we quantified the strength of association between the presence and severity of leukoaraiosis and post-thrombolysis sICH or 3- to 6-month modified Rankin Score >2. Results: Eleven eligible studies (n=7194) were pooled in meta-analysis. The risk of sICH was higher in patients with leukoaraiosis (OR, 1.55; 95% confidence interval [CI], 1.17-2.06; P=0.002) and severe leukoaraiosis (OR, 2.53; 95% CI, 1.92-3.34; P<0.0001) compared with patients without leukoaraiosis. Leukoaraiosis was an independent predictor of sICH in 6 included studies (n=4976; adjusted OR, 1.75; 95% CI, 1.35-2.27; P<0.0001). OR for leukoaraiosis and poor 3- to 6-month outcome was 2.02 (95% CI, 1.54-2.65; P<0.0001), with significant statistical heterogeneity (I(2), 75.7%; P=0.002). In adjusted analyses, leukoaraiosis was an independent predictor of poor outcome (n=3688; adjusted OR, 1.61; 95% CI, 1.44-1.79; P<0.0001). In post hoc analyses, including only leukoaraiosis patients in randomized controlled trials (IST-3 [third International Stroke Trial], NINDS [National Institute of Neurological Disorders and Stroke], ECASS-1-2 [European Cooperative Acute Stroke Study]; n=2234), tissue-type plasminogen activator versus control was associated with higher sICH risk (OR, 5.50; 95% CI, 2.49-12.13), but lower poor outcome risk (OR, 0.75; 95% CI, 0.60-0.95). Conclusions: Leukoaraiosis might increase post-intravenous thrombolysis sICH risk and poor outcome poststroke. Despite increased sICH risk, intravenous tissue-type plasminogen activator treatment has net clinical benefit in patients with leukoaraiosis. Given the risk of bias/confounding, these results should be considered hypothesis-generating and do not justify withholding intravenous thrombolysis.

Leukoaraiosis Severity and Outcomes after Mechanical Thrombectomy with Stent-Retriever Devices in Acute Ischemic Stroke

Leukoaraiosis and Earlier Neurological Outcome after Mechanical Thrombectomy in Acute Ischemic Stroke.

Association Between Leukoaraiosis and Poor Outcome is Not Due to Reperfusion Inefficiency after Intravenous Thrombolysis

Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke.

Effect of Baseline Infarct Size on Endovascular Thrombectomy with or Without Intravenous Alteplase in Stroke Patients: A Subgroup Analysis of a Randomized Trial (DIRECT-MT).

Leukoaraiosis severity and post-reperfusion outcomes in acute ischaemic stroke: A meta-analysis

Impact of Leukoaraiosis on the Infarct Growth Rate and Clinical Outcome in Acute Large Vessel Occlusion Stroke after Endovascular Thrombectomy.

Severe Leukoaraiosis Is Associated with Poor Outcome after Successful Recanalization of M1 Middle Cerebral Artery Occlusion Strokes

Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke

Impact of leukoaraiosis in patients with acute ischemic stroke treated with thrombectomy: a post hoc analysis of the DIRECT-MT trial

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Leukoaraiosis in patients with tirofiban before endovascular thrombectomy: A post hoc analysis of a multicentre randomized clinical trial

Leukoaraiosis and acute ischemic stroke

Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1)

Effect of Leukoaraiosis on Collateral Circulation in Acute Ischemic Stroke Treated with Endovascular Therapy: a Meta-Analysis

Study on the correlation between the severity of leukoaraiosis and symptomatic intracerebral hemorrhage after intravenous thrombolytic therapy in patients with acute cerebral infarction

Leukoaraiosis and early neurological recovery after intravenous thrombolysis

Leukoaraiosis is Associated with Clinical Symptom Severity, Poor Neurological Function Prognosis and Stroke Recurrence in Mild Intracerebral Hemorrhage: a Prospective Multi-Center Cohort Study.

Outcomes of endovascular treatment for acute anterior circulation ischemic stroke: Intracranial atherosclerotic versus cardioembolic stroke

Lenticulostriate Arteries Appearance Before Thrombectomy Predicts Good Outcome in Acute Middle Cerebral Artery Occlusion

Predictors of favorable functional outcomes for elderly patients undergoing endovascular thrombectomy for acute ischemic stroke